Defining Molecular Pathways Across Neuroendocrine Disease States
Three Neuroendocrine Tumor Research Foundation grant winners outlined research that aimed to deliver biology-driven strategies to patients.
The Neuroendocrine Tumor Research Foundation (NETRF) continues to catalyze transformative research through its annual grant awards, supporting investigators who are dismantling the traditional boundaries of neuroendocrine tumor (NET) management. A few of this year’s recipients, including Mauro Cives, MD, an associate professor of medical oncology in the Department of Interdisciplinary Medicine at University of Bari Aldo Moro; Suzann Duan, PhD, assistant professor at the School of Pharmacy & Pharmaceutical Sciences at University of California, Irvine; and Lynette Fernandez-Cuesta, PhD, team leader at the International Agency for Research on Cancer, spoke with CancerNetwork® about the research that ultimately resulted in the grant awards and how they plan to leverage the funds to advance research in their respective fields.